“Just Be Positive!” Toxic Positivity, ME/CFS and Fibromyalgia
Our culture is rampant with "positivity" messages and inspiring stories of overcoming the odds but sometimes the dark side needs to be acknowledged as well. Until we do that we can never truly be at peace. Check out some thoughts on "toxic positivity" and acknowledging the dark side of fibromyalgia and chronic fatigue syndrome in a blog co-written by Lori Madeira and Cort Johnson
Marijuana as Medicine for ME/CFS and/or Fibromyalgia Pt I: The Science Behind Cannabis
This is Part I of a five-part series on using marijuana or Cannabis as medicine for chronic fatigue syndrome (ME/CFS) and/or fibromaylgia (FM). The first two parts by Amber focus on the science behind using Cannabis and how to get started on it. Summary Cannabis...Dr. Peterson Attempts to AMPlify Therapies for M.E.
Dr. Peterson’s been using Ampligen in ME/CFS for 27 years. It seems like the drug has been sitting in limbo regarding ME/CFS forever – yet Ampligen is just one phase 3 trial away from becoming the first FDA-approved drug for ME/CFS – and no other...
A Ketamine Revolution for Depression and Pain? Spravato, Fibromyalgia and ME/CFS
For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam war and is still the preferred anesthetic in battlefield situations. It can be used to induce a...
The NIH ME/CFS Conference II: Lipkin’s Possibilities, Prusty’s Big Idea, Oh’s Search and Ron Davis on ALWAYS Moving Forward
Day two of the Conference – not all of which is covered here, started off with a physicians’ panel, then NIH Director Francis Collins showed up (covered later) just before the Intramural study presented some results, then it was onto Ian Lipkin, Dr. Oh,...Lives Interrupted Latest Story
Megan
Randolph, United States
Former occupation: Day care worker
$562,824
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
